选择针对重组甲状腺刺激激素受体蛋白的不同表位的aptamers
Jiajie Xu1,2,3, Ying Luo1, Zhenhao Long4
1Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
Analytical chemistry
|June 30, 2025
概括
研究人员开发了一种新的aptamer选择方法来识别向蛋白质特定部分的分子,从而推进甲状腺癌的诊断和治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 在生物标志物发现,疫苗开发和精准医学中的向疗法中,皮质的识别至关重要.
- 通过SELEX生成的aptamers是有价值的识别元素,但在具有挑战性的目标上选择它们作为本地表位是很困难的.
- 原生折叠的蛋白质制剂很少,阻碍了对特定表位体的体的发展.
研究的目的:
- 开发一种新的SELEX方法,用于产生针对目标蛋白质多个表位体的aptamer.
- 识别针对甲状腺刺激激素受体 (TSHR) 不同表位体的aptamer.
- 为了验证这些aptamers在甲状腺癌病理学中的诊断潜力.
主要方法:
- 开发了一种新的SELEX方法,用于产生针对TSHR的体.
- 使用Epitope-I特异性受体来固定TSHR,从而可以选择Epitope-II特异性受体.
- 在细胞和组织水平上使用流动细胞计,免疫光和免疫组织化学测试了aptamer的特异性和亲和力.
主要成果:
- 成功识别了针对TSHR蛋白质的独特表位体的新型吸收体.
- 开发的阿普坦体对TSHR结合具有很高的特异性和亲和力.
- 免疫组织化学证实了阿普坦体在识别TSHR阳性甲状腺瘤的诊断实用性.
结论:
- 这项研究提出了一种可通用的方法,用于开发针对多种蛋白质表位的体.
- 已识别的TSHR亚体显示出作为甲状腺癌诊断和治疗的分子探针的前景.
- 这种方法加速了对各种疾病的生物标志物和治疗点的发现.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
5.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
Tail-anchoring of Proteins in the ER Membrane
3.2K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.2K


